Pharma Focus Asia

Novavax Selects AGC Biologics to Manufacture Adjuvant Matrix-M ™ for New COVID-19 Vaccine

Wednesday, June 03, 2020

AGC Biologic s , a global biopharmaceutical contract development and manufacturing (CDMO) organization, has announced that it will partner with Novavax , Inc. (NASDAQ: NVAX), a late-phase biopharmaceutical company developing next-generation vaccines for serious infectious diseases, in large-scale production of GMP for all vital components of Novavax's coronavirus vaccine candidate, NVX-CoV2373. AGC Biologics will manufacture Matrix-M ™, an adjuvant component for the vaccine, in order to improve the immune response and stimulate high levels of neutralizing antibodies. NVX-CoV2373 is a stable prefusion protein created using Novavax's proprietary nanoparticle technology. AGC Biologics will streamline process development for Matrix-M production growth, greatly increasing Novavax's ability to deploy doses in 2020 and 2021.

"We are growing rapidly to successfully deploy a vital vaccine component for Novavax," explained AGC Biologics CEO Patricio Massera . "The urgency of aid to help produce a vaccine in the fight against COVID-19 could not be more important."

"The mission of AGC Biologics is to work side-by-side with our partners to create products that save and prolong life," said Mark Womack , Biological Manager, AGC Biologics. "Partnering with Novavax to manufacture this vaccine component is an incredible opportunity to make a profound positive difference."

"We have been impressed by the level of collaboration and commitment shown by AGC Biologics," said Timothy J. Hahn , senior vice president of processes and technology at Novavax. "It is an important strategic partner in expanding our adjuvant supply chain for NVX-CoV2373 and for other vaccines developed by Novavax, including our seasonal recombinant influenza vaccine, NanoFlu ™."

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024